Pentomone
Clinical data | |
---|---|
Other names | Lilly 113935; LY-113935 |
Drug class | Nonsteroidal antiandrogen |
ATC code |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
ChEMBL | |
Chemical and physical data | |
Formula | C24H26O5 |
Molar mass | 394.467 g·mol−1 |
3D model (JSmol) | |
SMILES
| |
InChI
|
Pentomone (INN, USAN) (developmental code name Lilly 113935 or LY-113935) is a nonsteroidal antiandrogen (NSAA) described as a "prostate growth inhibitor" which was never marketed.[1] It was synthesized and assayed in 1978.[1]
References[]
- ^ a b Elks J (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. pp. 949–. ISBN 978-1-4757-2085-3.
Categories:
- Drugs not assigned an ATC code
- Ethers
- Heterocyclic compounds with 5 rings
- Ketones
- Nonsteroidal antiandrogens
- Oxygen heterocycles
- Methoxy compounds
- Genito-urinary system drug stubs